Trial Profile
Clinical Trials Insight: 700049291
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Sep 2009
Price :
$35
*
At a glance
- Drugs Baricitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Incyte Corporation
- 27 Sep 2009 New trial record.